Back to resultsImpact of Pharmacist in Cardiology Service
Primary Purpose
Cardiomyopathy, Diabetic
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
pharmacist assessment
Sponsored by
About this trial
This is an interventional health services research trial for Cardiomyopathy, Diabetic
Eligibility Criteria
Inclusion Criteria:
- Diabetes type 2 patient hospitalized in cardiology service
- Hospitalization more than 24 hours
- with insuline or/and oral anti diabetic
Exclusion Criteria:
- diabètes type 1
- iatrogenic hyperglycaemia
- hospitalization for cardia angiography
Sites / Locations
- Groupe Hospitalier Paris Saint Joseph
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
pharmacist assessment intervention group
Arm Description
St Joseph Hospital pharmacist assess every diabetic patient hospitalized in cardiology service in term of antidiabetic treatment during the hospitalization
Outcomes
Primary Outcome Measures
Measurement of biological test glycosylated haemoglobin evolution between the entrance and discharge
Secondary Outcome Measures
Full Information
NCT ID
NCT03206294
First Posted
June 29, 2017
Last Updated
February 1, 2019
Sponsor
Fondation Hôpital Saint-Joseph
1. Study Identification
Unique Protocol Identification Number
NCT03206294
Brief Title
Impact of Pharmacist in Cardiology Service
Official Title
Presence of a Clinical Pharmacist in a Cardiology Department: What Impact on the Management of Diabetic Patients Within Care Pathways? Example of Inpatient Cardiac Patients at GHPSJ
Study Type
Interventional
2. Study Status
Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
March 8, 2017 (Actual)
Primary Completion Date
April 28, 2017 (Actual)
Study Completion Date
December 31, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondation Hôpital Saint-Joseph
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The coverage of the diabetes is a multidisciplinary care, with practitioners' implication(hospital and liberal), and other medical and paramedical profession: doctor, pharmacist, male nurse, nutritionist, etc. In fact there is a real importance of link between hospital and general medecine outside. That's why the pharmacist's presence during the hospitalization seems to be a good alternative to make the link between hospital and the outside pharmacist where patient take his treatment.
Hospital pharmacis proceed to a treatment conciliation at the entrance and at discharge.
By this conciliation the aim of the study is to show and quantify the impact of pharmacist presence on therapeutic target .
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiomyopathy, Diabetic
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
44 (Actual)
8. Arms, Groups, and Interventions
Arm Title
pharmacist assessment intervention group
Arm Type
Other
Arm Description
St Joseph Hospital pharmacist assess every diabetic patient hospitalized in cardiology service in term of antidiabetic treatment during the hospitalization
Intervention Type
Other
Intervention Name(s)
pharmacist assessment
Intervention Description
St Joseph Hospital pharmacist assess every diabetic patient hospitalized in cardiology service in term of antidiabetic treatment during the hospitalization
Primary Outcome Measure Information:
Title
Measurement of biological test glycosylated haemoglobin evolution between the entrance and discharge
Time Frame
5 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diabetes type 2 patient hospitalized in cardiology service
Hospitalization more than 24 hours
with insuline or/and oral anti diabetic
Exclusion Criteria:
diabètes type 1
iatrogenic hyperglycaemia
hospitalization for cardia angiography
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Romain CADOR, MD
Organizational Affiliation
GHPSJ
Official's Role
Principal Investigator
Facility Information:
Facility Name
Groupe Hospitalier Paris Saint Joseph
City
Paris
State/Province
Ile-de-France
ZIP/Postal Code
75014
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Impact of Pharmacist in Cardiology Service
We'll reach out to this number within 24 hrs